New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

astrazeneca limited - candesartan cilexetil 8mg;  ;   - tablet - 8 mg - active: candesartan cilexetil 8mg     excipient: carmellose calcium ferrous oxide hyprolose lactose monohydrate macrogol 8000 magnesium stearate maize starch purified water - treatment of hypertension

Stati Uniti - Ingliż - NLM (National Library of Medicine)

astrazeneca pharmaceuticals lp - candesartan cilexetil (unii: r85m2x0d68) (candesartan - unii:s8q36md2xx), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - candesartan cilexetil 16 mg - atacand hct is indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with atacand hct. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blo

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

crescent pharma ltd - candesartan cilexetil - oral tablet - 8mg

Stati Uniti - Ingliż - NLM (National Library of Medicine)

physicians total care, inc. - candesartan cilexetil (unii: r85m2x0d68) (candesartan - unii:s8q36md2xx), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - candesartan cilexetil 16 mg - when used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause injury and even death to the developing fetus. when pregnancy is detected, atacand hct should be discontinued as soon as possible. see warnings, fetal/neonatal morbidity and mortality. atacand hct is indicated for the treatment of hypertension. this fixed dose combination is not indicated for initial therapy (see dosage and administration). atacand hct is contraindicated in patients who are hypersensitive to any component of this product. because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - candesartan cilexetil, quantity: 32 mg; hydrochlorothiazide, quantity: 25 mg - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; iron oxide red; hyprolose; carmellose calcium; iron oxide yellow; macrogol 8000; maize starch - the treatment of hypertension. treatment should not be initiated with these fixed dose combinations.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - hydrochlorothiazide, quantity: 12.5 mg; candesartan cilexetil, quantity: 32 mg - tablet, uncoated - excipient ingredients: carmellose calcium; iron oxide yellow; lactose monohydrate; hyprolose; macrogol 8000; magnesium stearate; maize starch - the treatment of hypertension. treatment should not be initiated with these fixed dose combinations.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

ani pharmaceuticals, inc. - candesartan cilexetil (unii: r85m2x0d68) (candesartan - unii:s8q36md2xx), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - atacand hct is indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with atacand hct. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of hig

Stati Uniti - Ingliż - NLM (National Library of Medicine)

carilion materials management - candesartan cilexetil (unii: r85m2x0d68) (candesartan - unii:s8q36md2xx) - candesartan cilexetil 4 mg - atacand is indicated for the treatment of hypertension in adults and in children 1 to <17 years of age, to lower blood pressure. lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous an

Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

pco manufacturing - candesartan cilexetil - tablets - 16 milligram